The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
The Stryker Mako Robotic System uses artificial intelligence to improve surgical accuracy with real-time guidance, personalized planning, and precise execution
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Surpassing 1,000 Company Owned Company Operated stores
Subscribe To Our Newsletter & Stay Updated